These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 30916478)
1. The anti-prion RNA aptamer R12 disrupts the Alzheimer's disease-related complex between prion and amyloid β. Iida M; Mashima T; Yamaoki Y; So M; Nagata T; Katahira M FEBS J; 2019 Jun; 286(12):2355-2365. PubMed ID: 30916478 [TBL] [Abstract][Full Text] [Related]
2. A d-enantiomeric peptide interferes with heteroassociation of amyloid-β oligomers and prion protein. Rösener NS; Gremer L; Reinartz E; König A; Brener O; Heise H; Hoyer W; Neudecker P; Willbold D J Biol Chem; 2018 Oct; 293(41):15748-15764. PubMed ID: 30131337 [TBL] [Abstract][Full Text] [Related]
3. Soluble prion protein and its N-terminal fragment prevent impairment of synaptic plasticity by Aβ oligomers: Implications for novel therapeutic strategy in Alzheimer's disease. Scott-McKean JJ; Surewicz K; Choi JK; Ruffin VA; Salameh AI; Nieznanski K; Costa ACS; Surewicz WK Neurobiol Dis; 2016 Jul; 91():124-131. PubMed ID: 26949218 [TBL] [Abstract][Full Text] [Related]
5. Prion protein stabilizes amyloid-β (Aβ) oligomers and enhances Aβ neurotoxicity in a Younan ND; Chen KF; Rose RS; Crowther DC; Viles JH J Biol Chem; 2018 Aug; 293(34):13090-13099. PubMed ID: 29887525 [TBL] [Abstract][Full Text] [Related]
6. Accumulation of cellular prion protein within β-amyloid oligomer plaques in aged human brains. Takahashi RH; Yokotsuka M; Tobiume M; Sato Y; Hasegawa H; Nagao T; Gouras GK Brain Pathol; 2021 Sep; 31(5):e12941. PubMed ID: 33624334 [TBL] [Abstract][Full Text] [Related]
7. Selection of aptamers for amyloid beta-protein, the causative agent of Alzheimer's disease. Rahimi F; Bitan G J Vis Exp; 2010 May; (39):. PubMed ID: 20616783 [TBL] [Abstract][Full Text] [Related]
8. Preferential Recruitment of Conformationally Distinct Amyloid-β Oligomers by the Intrinsically Disordered Region of the Human Prion Protein. Madhu P; Mukhopadhyay S ACS Chem Neurosci; 2020 Jan; 11(1):86-98. PubMed ID: 31808343 [TBL] [Abstract][Full Text] [Related]
9. Binding between Prion Protein and Aβ Oligomers Contributes to the Pathogenesis of Alzheimer's Disease. Kong C; Xie H; Gao Z; Shao M; Li H; Shi R; Cai L; Gao S; Sun T; Li C Virol Sin; 2019 Oct; 34(5):475-488. PubMed ID: 31093882 [TBL] [Abstract][Full Text] [Related]
10. Cellular prion protein targets amyloid-β fibril ends via its C-terminal domain to prevent elongation. Bove-Fenderson E; Urano R; Straub JE; Harris DA J Biol Chem; 2017 Oct; 292(41):16858-16871. PubMed ID: 28842494 [TBL] [Abstract][Full Text] [Related]
12. Structural details of amyloid β oligomers in complex with human prion protein as revealed by solid-state MAS NMR spectroscopy. König AS; Rösener NS; Gremer L; Tusche M; Flender D; Reinartz E; Hoyer W; Neudecker P; Willbold D; Heise H J Biol Chem; 2021; 296():100499. PubMed ID: 33667547 [TBL] [Abstract][Full Text] [Related]
13. The cellular prion protein traps Alzheimer's Aβ in an oligomeric form and disassembles amyloid fibers. Younan ND; Sarell CJ; Davies P; Brown DR; Viles JH FASEB J; 2013 May; 27(5):1847-58. PubMed ID: 23335053 [TBL] [Abstract][Full Text] [Related]
14. PrP-grafted antibodies bind certain amyloid β-protein aggregates, but do not prevent toxicity. Mengel D; Hong W; Corbett GT; Liu W; DeSousa A; Solforosi L; Fang C; Frosch MP; Collinge J; Harris DA; Walsh DM Brain Res; 2019 May; 1710():125-135. PubMed ID: 30593771 [TBL] [Abstract][Full Text] [Related]
15. High molecular mass assemblies of amyloid-β oligomers bind prion protein in patients with Alzheimer's disease. Dohler F; Sepulveda-Falla D; Krasemann S; Altmeppen H; Schlüter H; Hildebrand D; Zerr I; Matschke J; Glatzel M Brain; 2014 Mar; 137(Pt 3):873-86. PubMed ID: 24519981 [TBL] [Abstract][Full Text] [Related]
16. Alzheimer's amyloid-β oligomers rescue cellular prion protein induced tau reduction via the Fyn pathway. Chen RJ; Chang WW; Lin YC; Cheng PL; Chen YR ACS Chem Neurosci; 2013 Sep; 4(9):1287-96. PubMed ID: 23805846 [TBL] [Abstract][Full Text] [Related]
17. Development of Alkaline Phosphatase-Fused Mouse Prion Protein and Its Application in Toxic Aβ Oligomer Detection. Tsukakoshi K; Kubo R; Ikebukuro K Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498917 [TBL] [Abstract][Full Text] [Related]
18. Identification of a Compound That Disrupts Binding of Amyloid-β to the Prion Protein Using a Novel Fluorescence-based Assay. Risse E; Nicoll AJ; Taylor WA; Wright D; Badoni M; Yang X; Farrow MA; Collinge J J Biol Chem; 2015 Jul; 290(27):17020-8. PubMed ID: 25995455 [TBL] [Abstract][Full Text] [Related]
19. Aβ induces its own prion protein N-terminal fragment (PrPN1)-mediated neutralization in amorphous aggregates. Béland M; Bédard M; Tremblay G; Lavigne P; Roucou X Neurobiol Aging; 2014 Jul; 35(7):1537-48. PubMed ID: 24602510 [TBL] [Abstract][Full Text] [Related]
20. The pathogenesis of soluble PrP fragments containing Aβ binding sites. Li B Virus Res; 2016 Jan; 211():194-8. PubMed ID: 26528810 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]